Ticker: SKBI, Company: SKYSTAR BIO-PHARMACEUTICAL CO, Type: 8-K, Date: 2009-12-09
Original SEC Filing: Click here

---

Webplus: SKBI/20091209/8-K_1/2_EX-99.1/000.htm SEC Original: v168568_ex99-1.htm
Skystar Bio-Pharmaceutical Acquires Exclusive Aquaculture Vaccine Technology and Provides Operational Update on Facility Development New Vaccine Technology to Address Company-Estimated $150 Million Market Opportunity Veterinary Vaccine Facility Launch Extended to First Quarter of 2010 to Accommodate New Aquaculture Vaccine Line XI’AN, CHINA, December 9 , 2009 — Skystar Bio-Pharmaceutical Company Skystar will manufacture its aquaculture vaccine in its new 51,000

---

---

Webplus: SKBI/20091209/8-K_1/1/000.htm SEC Original: v168568_8k.htm
FORM 8-K CURRENT REPORT Date of report (Date of earliest event reported): December 9, 2009 SKYSTAR BIO-PHARMACEUTICAL COMPANY Nevada 000-28153 33-0901534 (State or other jurisdiction of incorporation or organization) (Commission File No.) (IRS Employer Identification No.) Rm. 10601, Jiezuo Plaza, No.4, Fenghui Road South, Gaoxin District, Xi’an, Shaanxi Province, P.R. China (8629) 8819-3188 (Issuer Telephone Number) N/A (Former name or

---

Company Information:

Ticker: SKBI, Company: SKYSTAR BIO-PHARMACEUTICAL CO, Type: 8-K, Date: 2009-12-09CIK: 0001076939, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
RM 10601, JIEZUO PLAZA, NO. 4, FENGHUI ROAD SOUTH, GAOXIN DISTRICT
XIAN PROVINCE